The University of Southampton
University of Southampton Institutional Repository

Partial replication of a DRD4 association in ADHD individuals using a statistically derived quantitative trait for ADHD in a family-based association test

Partial replication of a DRD4 association in ADHD individuals using a statistically derived quantitative trait for ADHD in a family-based association test
Partial replication of a DRD4 association in ADHD individuals using a statistically derived quantitative trait for ADHD in a family-based association test
Background: Lisdexamfetamine dimesylate is a therapeutically inactive prodrug in which d-amphetamine is covalently bound to l-lysine, a naturally occurring amino acid. Pharmacologically active d-amphetamine is released from lisdexamfetamine following oral ingestion.
Methods: This phase 2, randomized, double-blind, placebo- and active-controlled crossover study compared the efficacy and safety of lisdexamfetamine (LDX: 30, 50, or 70 mg) with placebo, with mixed amphetamine salts extended-release (MAS XR: 10, 20, or 30 mg) included as a reference arm of the study, in 52 children aged 6 to 12 years with attention-deficit/hyperactivity disorder (ADHD) in an analog classroom setting. The primary efficacy measure was the Swanson, Kotkin, Agler, M-Flynn, and Pelham (SKAMP) Rating Scale; secondary efficacy measures included the Permanent Product Measure of Performance (PERMP) Derived Measures, and the Clinical Global Impression (CGI) Scale.
Results: LDX treatment significantly improved scores on SKAMP-deportment, SKAMP-attention, PERMP-attempted, PERMP-correct, and CGI-improvement from baseline. Adverse events were similar for both active treatments.
Conclusions: In a laboratory classroom environment, LDX significantly improved ADHD symptoms versus placebo in school-age children with ADHD.
ADHD, amphetamine, analog classroom, double blind, lisdexamfetamine, mixed amphetamine salts
0006-3223
985-990
Lasky-Su, J.
171c2348-a33d-4a69-84a4-9760ddbcce54
Banaschewski, T.
ca2651e5-143a-4171-b6d0-3e3853b684d8
Buitelaar, J.
fa22aba5-1307-4627-9ae8-e564013a5af8
Franke, B.
d3276e6a-292a-489d-b589-de3af1b0162d
Brookes, K.
c9a700f0-57c9-4d8c-b75d-5ac2175d4d37
Sonuga-Barke, E.
bc80bf95-6cf9-4c76-a09d-eaaf0b717635
Ebstein, R.
451c2126-5196-41ff-81f9-490a200398e9
Eisenberg, J.
d91585a2-2d07-45b3-85e1-53b1ef09c0ea
Gill, M.
ae2696a2-c4b5-4a68-8f42-f26dbed5e251
Manor, I.
4e8bcd80-e32d-420c-9110-de08cff4aee3
Miranda, A.
8aa5d3d9-71b4-4498-b369-9fba532f5d4e
Mulas, F.
44612276-b250-4f01-97b3-46e115f49a25
Oades, R.D.
89c5ac77-d90a-4d61-8cd0-826e4c90441c
Roeyers, H.
c97b7f56-f514-44cb-b7e2-545c68583d6e
Rothenberger, A.
f946fbda-7ceb-46b0-b48d-23cdaa4016aa
Sergeant, J.
76cfd9c5-bab9-4119-b5c2-af1749e22c71
Steinhausen, H-C.
d9f629a6-47dc-4bf9-9fcf-ee516b5aa315
Taylor, E.
4528abc7-ae2b-4268-a646-68f9c2cae4d3
Zhou, K.
b7f35885-4647-46b1-acf8-c3bae7f50755
Thompson, M.
bfe8522c-b252-4771-8036-744e93357c67
Asherson, P.
4ecfa0c9-ea9c-47b9-aae8-429822c6c7ee
Faraone, S.V.
023439f0-0461-4037-9b79-27e0c25a9488
Lasky-Su, J.
171c2348-a33d-4a69-84a4-9760ddbcce54
Banaschewski, T.
ca2651e5-143a-4171-b6d0-3e3853b684d8
Buitelaar, J.
fa22aba5-1307-4627-9ae8-e564013a5af8
Franke, B.
d3276e6a-292a-489d-b589-de3af1b0162d
Brookes, K.
c9a700f0-57c9-4d8c-b75d-5ac2175d4d37
Sonuga-Barke, E.
bc80bf95-6cf9-4c76-a09d-eaaf0b717635
Ebstein, R.
451c2126-5196-41ff-81f9-490a200398e9
Eisenberg, J.
d91585a2-2d07-45b3-85e1-53b1ef09c0ea
Gill, M.
ae2696a2-c4b5-4a68-8f42-f26dbed5e251
Manor, I.
4e8bcd80-e32d-420c-9110-de08cff4aee3
Miranda, A.
8aa5d3d9-71b4-4498-b369-9fba532f5d4e
Mulas, F.
44612276-b250-4f01-97b3-46e115f49a25
Oades, R.D.
89c5ac77-d90a-4d61-8cd0-826e4c90441c
Roeyers, H.
c97b7f56-f514-44cb-b7e2-545c68583d6e
Rothenberger, A.
f946fbda-7ceb-46b0-b48d-23cdaa4016aa
Sergeant, J.
76cfd9c5-bab9-4119-b5c2-af1749e22c71
Steinhausen, H-C.
d9f629a6-47dc-4bf9-9fcf-ee516b5aa315
Taylor, E.
4528abc7-ae2b-4268-a646-68f9c2cae4d3
Zhou, K.
b7f35885-4647-46b1-acf8-c3bae7f50755
Thompson, M.
bfe8522c-b252-4771-8036-744e93357c67
Asherson, P.
4ecfa0c9-ea9c-47b9-aae8-429822c6c7ee
Faraone, S.V.
023439f0-0461-4037-9b79-27e0c25a9488

Lasky-Su, J., Banaschewski, T., Buitelaar, J., Franke, B., Brookes, K., Sonuga-Barke, E., Ebstein, R., Eisenberg, J., Gill, M., Manor, I., Miranda, A., Mulas, F., Oades, R.D., Roeyers, H., Rothenberger, A., Sergeant, J., Steinhausen, H-C., Taylor, E., Zhou, K., Thompson, M., Asherson, P. and Faraone, S.V. (2007) Partial replication of a DRD4 association in ADHD individuals using a statistically derived quantitative trait for ADHD in a family-based association test. Biological Psychiatry, 62 (9), 985-990. (doi:10.1016/j.biopsych.2007.03.006).

Record type: Article

Abstract

Background: Lisdexamfetamine dimesylate is a therapeutically inactive prodrug in which d-amphetamine is covalently bound to l-lysine, a naturally occurring amino acid. Pharmacologically active d-amphetamine is released from lisdexamfetamine following oral ingestion.
Methods: This phase 2, randomized, double-blind, placebo- and active-controlled crossover study compared the efficacy and safety of lisdexamfetamine (LDX: 30, 50, or 70 mg) with placebo, with mixed amphetamine salts extended-release (MAS XR: 10, 20, or 30 mg) included as a reference arm of the study, in 52 children aged 6 to 12 years with attention-deficit/hyperactivity disorder (ADHD) in an analog classroom setting. The primary efficacy measure was the Swanson, Kotkin, Agler, M-Flynn, and Pelham (SKAMP) Rating Scale; secondary efficacy measures included the Permanent Product Measure of Performance (PERMP) Derived Measures, and the Clinical Global Impression (CGI) Scale.
Results: LDX treatment significantly improved scores on SKAMP-deportment, SKAMP-attention, PERMP-attempted, PERMP-correct, and CGI-improvement from baseline. Adverse events were similar for both active treatments.
Conclusions: In a laboratory classroom environment, LDX significantly improved ADHD symptoms versus placebo in school-age children with ADHD.

This record has no associated files available for download.

More information

Published date: 1 November 2007
Keywords: ADHD, amphetamine, analog classroom, double blind, lisdexamfetamine, mixed amphetamine salts

Identifiers

Local EPrints ID: 49703
URI: http://eprints.soton.ac.uk/id/eprint/49703
ISSN: 0006-3223
PURE UUID: ec713ea7-e13c-48c5-b3b6-463ac153e7a4

Catalogue record

Date deposited: 23 Nov 2007
Last modified: 15 Mar 2024 09:58

Export record

Altmetrics

Contributors

Author: J. Lasky-Su
Author: T. Banaschewski
Author: J. Buitelaar
Author: B. Franke
Author: K. Brookes
Author: E. Sonuga-Barke
Author: R. Ebstein
Author: J. Eisenberg
Author: M. Gill
Author: I. Manor
Author: A. Miranda
Author: F. Mulas
Author: R.D. Oades
Author: H. Roeyers
Author: A. Rothenberger
Author: J. Sergeant
Author: H-C. Steinhausen
Author: E. Taylor
Author: K. Zhou
Author: M. Thompson
Author: P. Asherson
Author: S.V. Faraone

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×